CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER di E. N. Imyanitov, T. Yu. Semiglazova

Testo

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER di N. A. Kozyavin, T. Yu. Semiglazova

Testo

Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer di V. A. Kostorov, T. Yu. Semiglazova, A. V. Pavlysh

Testo

DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST di T. Yu. Semiglazova, G. M. Teletaeva, N. A. Kozyavin, A. V. Zagatina

Testo

The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state di T. Yu. Semiglazova, N. A. Brish, T. Yu. Galunova, A. S. Bernatskiy, V. V. Semiglazov

Testo

Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors di Van Shu, A. S. Artemieva, E. A. Busco, V. V. Semiglazov, T. Yu. Semiglazova

Testo

The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study) di V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev

Testo

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer di T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

Testo

Features of nutritional support during stem cell transplantation di S. A. Volchenkov, L. V. Filatova, E. V. Cherkasova, A. K. Koviazin, S. V. Lyubimov, I. S. Zyuzgin, T. Yu. Semiglazova

Testo

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) di V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Testo

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment di V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

Testo

International rehabilitation model for oncological patients di T. Yu. Semiglazova, V. A. Klyuge, B. S. Kasparov, K. O. Kondratyeva, A. A. Krutov, M. A. Zernova, V. A. Chulkova, V. V. Semiglazov

Testo

2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance di V. A. Alexandrov, G. V. Tochilnikov, S. V. Shatik, A. N. Stukov, O. A. Beljaeva, E. V. Bashkatova, V. G. Dranishnikov, T. Yu. Semiglazova

Testo

Activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propandyоl (chlonisol) versus lomustine in intracranial transplanted tumor model in mice di Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova

Testo

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma di Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova

Testo

Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma di I. G. Murazov, A. N. Stukov, Iu. G. Zmitrichenko, A. O. Niuganen, G. V. Tochilnikov, D. Ch. Latipova, L. V. Filatova, T. Yu. Semiglazova

Testo

Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer di R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova

Testo

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction di A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko

Testo

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma di E. V. Kharchenko, T. Yu. Semiglazova, A. S. Artem’yeva, G. S. Kireyeva, I. L. Polyatskin, I. S. Zyuzgin, L. V. Filatova, Yu. A. Chudinovskikh, M. S. Motalkina, Yu. A. Oleynik

Testo

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... di E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

Testo